Výsledky vyhledávání - "Papadaki, H A"

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

P102 - Topic: AS06-Prognosis/AS06b-Predictive factors of response to treatment: NOVEL PREDICTIVE INDICATORS IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC NEOPLASMS (HR-MDS) TREATED WITH 5-AZACYTIDINE: CUMULATIVE DATA FROM THE HELLENIC MDS STUDY GROUP

Publikováno v: In Leukemia Research May 2023 128 Supplement

Zobrazit plný text záznamu

Real-life Experience With Rituximab-CHOP Every 21 or 14 Days in Primary Mediastinal Large B-cell Lymphoma

Autor: Karakatsanis, S.J. Bouzani, M. Symeonidis, A. Angelopoulou, M.K. Papageorgiou, S.G. Michail, M. Gainaru, G. Kourti, G. sachanas, S. Kalpadakis, C. Katodritou, E. Leonidopoulou, T. Kotsianidis, I. Hatzimichael, E. Kotsopoulou, M. Dimou, M. Variamis, E. Boutsis, D. Kanellias, N. Dimopoulou, M.N. Michali, E. Karianakis, G. Tsirkinidis, P. Vadikolia, C. Poziopoulos, C. Pigaditou, A. Vrakidou, E. Economopoulos, T. Kyriazopoulou, L. Siakantaris, M.P. Kyrtsonis, M.-C. Anargyrou, K. Papaioannou, M. Hatjiharissi, E. Vervessou, E. Tsirogianni, M. Palassopoulou, M. Stefanoudaki, E. Zikos, P. Tsirigotis, P. Tsourouflis, G. Assimakopoulou, T. Verrou, E. Papadaki, H. Lampropoulou, P. Dimopoulos, M.-A. Pappa, V. Konstantopoulos, K. Karmiris, T. Roussou, P. Panayiotidis, P. Pangalis, G.A. Vassilakopoulos, T.P.

Background/Aim: Primary mediastinal large Bcell lymphoma (PMLBCL) is an aggressive B-cell non- Hodgkin lymphoma (NHL), whose prognosis has greatly improved since the incorporation of the anti-CD20 monoclonal antibody rituximab into current therapeuti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::aac0fd8434bc5524bf5c24e52f2d534c
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3219445

Zobrazit plný text záznamu

Akademický článek

17 Myelodysplastic syndromes with unilineage cytopenia (neutropenia/thrombocytopenia)

Autor: Papadaki, H.

Publikováno v: In Leukemia Research 2009 33 Supplement 1:S11-S14

Zobrazit plný text záznamu

Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies

Autor: Vassilakopoulos, T.P. Papageorgiou, S.G. Angelopoulou, M.K. Chatziioannou, S. Prassopoulos, V. Karakatsanis, S. Arapaki, M. Mellios, Z. Sachanas, S. Kalpadakis, C. Katodritou, E. Leonidopoulou, T. Kotsianidis, I. Hatzimichael, E. Kotsopoulou, M. Dimou, M. Variamis, E. Boutsis, D. Terpos, E. Michali, E. Karianakis, G. Tsirkinidis, P. Vadikolia, C. Poziopoulos, C. Pigaditou, A. Vrakidou, E. Siakantaris, M.P. Kyrtsonis, M.-C. Symeonidis, A. Anargyrou, K. Papaioannou, M. Chatziharissi, E. Vervessou, E. Tsirogianni, M. Palassopoulou, M. Gainaru, G. Mainta, C. Tsirigotis, P. Assimakopoulou, T. Konstantinidou, P. Papadaki, H. Dimopoulos, M.-A. Pappa, V. Karmiris, T. Roussou, P. Datseris, I. Panayiotidis, P. Konstantopoulos, K. Pangalis, G.A. Rondogianni, P.

End-of-treatment (EoT) PET/CT is used as a guide to omit radiotherapy (RT) patients with primary mediastinal large B-cell lymphoma (PMBCL). We present the mature and extended results of a retrospective study evaluating the prognostic significance of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::3bb976ff80b447b9a8f16d9cd7908710
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3119407

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Effectiveness of 5-Azacytidine in older patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia: A retrospective analysis of the Hellenic (Greek) MDS Study Group

Autor: Papageorgiou, S.G. Kontos, C.K. Kotsianidis, I. Karousi, P. Symeonidis, A. Galanopoulos, A. Bouchla, A. Hatzimichael, E. Repousis, P. Zikos, P. Viniou, N.-A. Poulakidas, E. Vassilakopoulos, T.P. Diamantopoulos, P. Mparmparousi, D. Bouronikou, E. Papadaki, H. Panayiotidis, P. Pappa, V.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::455694710eb6e3411115f73e2db57d0e
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3105245

Zobrazit plný text záznamu

Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromes

Autor: Papageorgiou, S.G. Kotsianidis, I. Bouchla, A. Symeonidis, A. Galanopoulos, A. Viniou, N.-A. Hatzimichael, E. Vassilakopoulos, T.P. Gogos, D. Megalakaki, A. Zikos, P. Diamantopoulos, P. Kourakli, A. Giannoulia, P. Papoutselis, M. Poulakidas, E. Arapaki, M. Vardi, A. Anagnostopoulos, A. Mparmparousi, D. Papaioannou, M. Bouronikou, E. Dimou, M. Papadaki, H. Panayiotidis, P. Pappa, V.

Background: 5-azacytidine (5-AZA) improves survival of patients with higher-risk myelodysplastic syndromes (MDSs) and oligoblastic acute myeloid leukemia (AML); however, predictive factors for response and outcome have not been consistently studied.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::2f1346cbba3a388fdd0c272409f84d91
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3104904

Zobrazit plný text záznamu

Characteristics of Long-Term Survival in Patients With Myelodysplastic Syndrome Treated With 5-Azacyditine: Results From the Hellenic 5-Azacytidine Registry

Autor: Diamantopoulos, P.T. Pappa, V. Symeonidis, A. Kotsianidis, I. Galanopoulos, A. Papadaki, H. Anagnostopoulos, A. Vassilopoulos, G. Zikos, P. Hatzimichael, E. Papaioannou, M. Megalakaki, A. Kotsopoulou, M. Repousis, P. Dimou, M. Solomou, E. Pontikoglou, C. Kyriakakis, G. Tsokanas, D. Papoutselis, M.-K. Papageorgiou, S. Kourakli, A. Panayiotidis, P. Viniou, N.-A.

Background: Hypomethylating agents have altered the prognosis of myelodysplastic syndrome (MDS) so that long-term survival is now a feasible treatment goal. Patients and Methods: We analyzed data from patients with MDS treated with 5-azacytidine reco

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::9769b866e314facc62de343ca9b5b9f0
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078653

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání